Company: GVH
Filing Date: 2025-04-15
Form Type: DRS
Source: 0001641172-25-004806
Chunk: 55

Company: Globavend Holdings Ltd
Filing Date: 2025-04-15
Form: DRS
Chunk 55
---
 independent directors and our nominating and corporate governance and compensation committees might not consist entirely of independent directors. Accordingly, during any time while we remain a controlled company relying on the exemption and during any transition period following a time when we are no longer a controlled company, you would not have the same protections afforded to shareholders of companies that are subject to all of the corporate governance requirements of Nasdaq. Our status as a controlled company could cause our Ordinary Shares to be less attractive to certain investors or otherwise harm our trading price.

In addition, the interests of these shareholders may not be the same as or may even conflict with your interests. For example, these shareholders could attempt to delay or prevent a change in control of us, even if such change in control would benefit our other shareholders, which could deprive our shareholders of an opportunity to receive a premium for their Ordinary Shares as part of a sale of us or our assets and might affect the prevailing market price of our Ordinary Shares due to investors’ perceptions that conflicts of interest may exist or arise. As a result, this concentration of ownership may not be in the best interests of our other shareholders.

<div align='center'>Risks Related to the Units and the Securities Offered</div>

There is no public market for the Series A Warrants, the Series B Warrants or the Pre-Funded Warrants.

The
Series A Warrants, the Series B Warrants and the Pre-Funded Warrants offered in this Offering are not and
will not be listed on any securities exchange. Also, we do not intend to apply to have the Warrants listed on any securities exchange.
Consequently, there is no public trading market for the Warrants, and we do not expect a market to develop. Accordingly, investors may
find it difficult to dispose of, or to obtain accurate quotations as to the market value of, the Warrants. This lack of a trading
market could result in investors being unable to liquidate their investment in the Warrants or to sell them at a price that reflects
their value. The absence of a public market for these securities could also reduce the liquidity and market price of our Ordinary Shares
to which these Warrants are exercisable. Investors should be prepared to bear the risk of investment in the Warrants indefinitely.

| 25 |

Lack of voting rights.

Holders of the Warrants will not have the same voting rights as those associated with our Ordinary Shares and may have no voting rights with respect to the shares underlying the Warrants until such Ordinary Shares are acquired upon